Blog
 
      
      Human–AI Synergy in Retrosynthetic Analysis and Route Optimization of Balinatunfib
Discover how AI-driven retrosynthesis and human expertise converge in the development of Balinatunfib (SAR-441566), a first-in-class small-molecule TNF-α inhibitor. Learn about its unique allosteric mechanism, clinical progress, and how ChemAIRS revolutionizes route optimization, enabling cost-effective and scalable synthesis in modern drug discovery.
